Lieping Chen

Citado por

	Total	Desde 2016
Citas	79692	39252
Índice h	119	77
Índice i10	304	232

8000

4000

2000

6000

199519961997199819992000200120022003200420052006200720082009201020112012201320142015201620172018201920202021223 314 304 397 444 442 480 676 986 1239 1594 1963 2262 2390 2409 2366 2779 3112 4377 4548 6140 6910 7267 7229 7327 7970 2530

Acceso público

Ver todo

86 artículos

4 artículos

disponibles

no disponibles

Basado en requisitos de financiación

Coautores

scott stromeUniversity of Tennessee Health Science CenterDirección de correo verificada de uthsc.edu
Andrew PardollJohns Hopkins University school of medicineDirección de correo verificada de jhmi.edu
Haidong Dong, MD, PhD.Professor of Immunology, Mayo ClinicDirección de correo verificada de mayo.edu
Weiping ZouCharles B. de Nancrede Professor of Pathology, Immunology, Biology, and Surgery; University ofDirección de correo verificada de med.umich.edu
Andrei ChapovalAltai State UniversityDirección de correo verificada de email.asu.ru
Robert A. AndersJohns HopkinsDirección de correo verificada de jhmi.edu
Roy S. Herbst, MD, PhDYale School of Medicine | Yale Cancer Center | Smilow Cancer Hospital at Yale-New HavenDirección de correo verificada de yale.edu
Ryan WilcoxDirección de correo verificada de med.umich.edu
David RimmYale UniversityDirección de correo verificada de yale.edu
Gabriel SicaEmory University School of Medicine, Department of Pathology and Laboratory MedicineDirección de correo verificada de emoryhealthcare.org
Charles G. DrakeImmunologyDirección de correo verificada de jhmi.edu
Andrew S. FliesSenior Research Fellow - Menzies Institute for Medical Research, University of TasmaniaDirección de correo verificada de utas.edu.au
Xue HanAssociate Research Scientist, Yale UniversityDirección de correo verificada de yale.edu
Tyler CurielDirección de correo verificada de uthscsa.edu
Jun WangAssistant Professor of Pathology, New York University (NYU) Grossman School of MedicineDirección de correo verificada de nyulangone.org
George CoukosUniversity of LausanneDirección de correo verificada de chuv.ch
Vamsidhar Velcheti MD FACP FCCPYale UniversityDirección de correo verificada de yale.edu
Linghua ZhengAssociate Research ScientistDirección de correo verificada de yale.edu
Peter LinsleyMember and Director | Systems Immunology Benaroya Research Institute at Virginia Mason 1201 NinthDirección de correo verificada de benaroyaresearch.org
Sudarshan Anand PhDAssociate Professor, OHSU/Knight Cancer Institute, PortlandDirección de correo verificada de ohsu.edu

Lieping Chen

Department of Immunobiology, Yale University

Dirección de correo verificada de yale.edu - Página principal

Immunology T-cell biology cancer immunotherapy


Título Ordenar por citas Ordenar por año Ordenar por título	Citado por Citado por	Año
Safety, activity, and immune correlates of anti–PD-1 antibody in cancer SL Topalian, FS Hodi, JR Brahmer, SN Gettinger, DC Smith, ... New England Journal of Medicine 366 (26), 2443-2454, 2012	10326	2012
Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival TJ Curiel, G Coukos, L Zou, X Alvarez, P Cheng, P Mottram, ... Nature medicine 10 (9), 942-949, 2004	5242	2004
Tumor-associated B7-H1 promotes T-cell apoptosis: a potential mechanism of immune evasion H Dong, SE Strome, DR Salomao, H Tamura, F Hirano, DB Flies, ... Nature medicine 8 (8), 793-800, 2002	4561	2002
Phase I study of single-agent anti–programmed death-1 (MDX-1106) in refractory solid tumors: safety, clinical activity, pharmacodynamics, and immunologic correlates JR Brahmer, CG Drake, I Wollner, JD Powderly, J Picus, WH Sharfman, ... Journal of clinical oncology 28 (19), 3167, 2010	2663	2010
B7-H1, a third member of the B7 family, co-stimulates T-cell proliferation and interleukin-10 secretion H Dong, G Zhu, K Tamada, L Chen Nature medicine 5 (12), 1365-1369, 1999	2335	1999
Molecular mechanisms of T cell co-stimulation and co-inhibition L Chen, DB Flies Nature Reviews Immunology 13 (4), 227-242, 2013	2140	2013
Colocalization of inflammatory response with B7-h1 expression in human melanocytic lesions supports an adaptive resistance mechanism of immune escape JM Taube, RA Anders, GD Young, H Xu, R Sharma, TL McMiller, S Chen, ... Science translational medicine 4 (127), 127ra37-127ra37, 2012	1833	2012
Association of PD-1, PD-1 ligands, and other features of the tumor immune microenvironment with response to anti–PD-1 therapy JM Taube, A Klein, JR Brahmer, H Xu, X Pan, JH Kim, L Chen, DM Pardoll, ... Clinical cancer research 20 (19), 5064-5074, 2014	1823	2014
Inhibitory B7-family molecules in the tumour microenvironment W Zou, L Chen Nature Reviews Immunology 8 (6), 467-477, 2008	1515	2008
Co-inhibitory molecules of the B7–CD28 family in the control of T-cell immunity L Chen Nature Reviews Immunology 4 (5), 336-347, 2004	1381	2004
Costimulation of antitumor immunity by the B7 counterreceptor for the T lymphocyte molecules CD28 and CTLA-4 L Chen, S Ashe, WA Brady, I Hellström, KE Hellström, JA Ledbetter, ... Cell 71 (7), 1093-1102, 1992	1319	1992
PD-L1 (B7-H1) and PD-1 pathway blockade for cancer therapy: Mechanisms, response biomarkers, and combinations W Zou, JD Wolchok, L Chen Science translational medicine 8 (328), 328rv4-328rv4, 2016	1213	2016
Blockade of B7-H1 improves myeloid dendritic cell–mediated antitumor immunity TJ Curiel, S Wei, H Dong, X Alvarez, P Cheng, P Mottram, R Krzysiek, ... Nature medicine 9 (5), 562-567, 2003	1205	2003
Blockade of B7-H1 and PD-1 by monoclonal antibodies potentiates cancer therapeutic immunity F Hirano, K Kaneko, H Tamura, H Dong, S Wang, M Ichikawa, C Rietz, ... Cancer research 65 (3), 1089-1096, 2005	1045	2005
Monoclonal antibodies against the 4-1BB T-cell activation molecule eradicate established tumors I Melero, WW Shuford, SA Newby, A Aruffo, JA Ledbetter, KE Hellström, ... Nature medicine 3 (6), 682-685, 1997	953	1997
B7-H3: a costimulatory molecule for T cell activation and IFN-γ production AI Chapoval, J Ni, JS Lau, RA Wilcox, DB Flies, D Liu, H Dong, GL Sica, ... Nature immunology 2 (3), 269-274, 2001	932	2001
Costimulatory B7-H1 in renal cell carcinoma patients: Indicator of tumor aggressiveness and potential therapeutic target RH Thompson, MD Gillett, JC Cheville, CM Lohse, H Dong, WS Webster, ... Proceedings of the National Academy of Sciences 101 (49), 17174-17179, 2004	869	2004
B7-H4, a molecule of the B7 family, negatively regulates T cell immunity GL Sica, IH Choi, G Zhu, K Tamada, SD Wang, H Tamura, AI Chapoval, ... Immunity 18 (6), 849-861, 2003	831	2003
Anti–PD-1/PD-L1 therapy of human cancer: past, present, and future L Chen, X Han The Journal of clinical investigation 125 (9), 3384-3391, 2015	807	2015
Programmed death ligand-1 expression in non-small cell lung cancer V Velcheti, KA Schalper, DE Carvajal, VK Anagnostou, KN Syrigos, ... Laboratory investigation 94 (1), 107-116, 2014	724	2014

El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.

Artículos 1–20

Citas por año

Citas duplicadas

Citas combinadas

Añadir coautoresCoautores

Subir PDF

Seguir a este autor

Citado por

Coautores